- Trials with a EudraCT protocol (83)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
83 result(s) found for: Lower abdominal pain.
Displaying page 1 of 5.
EudraCT Number: 2020-002699-10 | Sponsor Protocol Number: 80015401 | Start Date*: 2021-01-06 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: High dose Ropivacaine versus moderate dose for quadratus lumborum block as postoperative analgesia after percutaneous nephrolithotomy – a blinded randomized non-inferiority study | |||||||||||||
Medical condition: Postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000623-18 | Sponsor Protocol Number: TAP5 | Start Date*: 2007-10-18 | |||||||||||
Sponsor Name:Dept of Anaesthesia, University College Hospital, Galway | |||||||||||||
Full Title: A comparison between the use of opioid based patient controlled analgesia and ultrasound guided continuous Transversus Abdominis Plane Block in the management of postoperative pain following unilat... | |||||||||||||
Medical condition: Postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002350-90 | Sponsor Protocol Number: EFC17045 | Start Date*: 2022-04-01 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, 12 month Phase 3 study to evaluate the effect of venglustat on neuropathic and abdominal pain in male and female participants ≥16 Years of Age with F... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) DE (Ongoing) DK (Trial now transitioned) AT (Trial now transitioned) PL (Trial now transitioned) GR (Trial now transitioned) NO (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004867-19 | Sponsor Protocol Number: v1330032015 | Start Date*: 2015-02-24 |
Sponsor Name:Clinic for General Anesthesiology, Intensive Care and Pain Management | ||
Full Title: Perioperative fluid management in patients receiving major abdominal surgery – Effects of normal saline versus an acetate buffered balanced infusion solution on the necessity of catecholamines for ... | ||
Medical condition: hemodynamic stability of patients undergoing major surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-002708-28 | Sponsor Protocol Number: REDIV/002/17 | Start Date*: 2018-02-23 | |||||||||||
Sponsor Name:Alfasigma S.p.a | |||||||||||||
Full Title: Rifaximin delayed release (400 mg tablet) for the prevention of recurrent acute diverticulitis and diverticular complications. A phase II, multicenter, double-blind, placebo-controlled, randomized ... | |||||||||||||
Medical condition: Prevention of recurrent acute diverticulitis and diverticular complications | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Completed) HU (Completed) FR (Completed) NL (Completed) GB (GB - no longer in EU/EEA) PT (Completed) IT (Prematurely Ended) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002120-41 | Sponsor Protocol Number: CXA-cIAI-10-09 | Start Date*: 2012-02-08 |
Sponsor Name:Cubist Pharmaceuticals, Inc. | ||
Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVENOUS CXA-201 WITH THAT OF MEROPENEM IN COMPLICATED INTRAABDOMINAL INFECTIONS | ||
Medical condition: Complicated Intra abdominal Infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) DE (Completed) PL (Completed) BG (Completed) LT (Completed) EE (Completed) LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004138-41 | Sponsor Protocol Number: LPS16145 | Start Date*: 2020-07-02 | |||||||||||
Sponsor Name:Sanofi-Aventis Groupe | |||||||||||||
Full Title: A phase IV randomized, double-blind, 3-treatment, 3-period, 6-sequence crossover clinical trial to assess the efficacy and safety of hyoscine butylbromide co-administered with ibuprofen compared to... | |||||||||||||
Medical condition: Dysmenorrhoea | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002119-27 | Sponsor Protocol Number: CXA-cIAI-10-08 | Start Date*: 2012-01-25 |
Sponsor Name:Cubist Pharmaceuticals, Inc. | ||
Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVENOUS CXA-201 WITH THAT OF MEROPENEM IN COMPLICATED INTRAABDOMINAL INFECTIONS | ||
Medical condition: Complicated Intraabdominal Infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) BE (Completed) LV (Completed) SK (Completed) LT (Completed) EE (Completed) RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004609-85 | Sponsor Protocol Number: UV2005/01 | Start Date*: 2008-03-18 | ||||||||||||||||
Sponsor Name:OM Pharma SA | ||||||||||||||||||
Full Title: Multicentre, randomised, double-blind, placebo-controlled clinical study to assess the efficacy and safety of UroVaxom in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) | ||||||||||||||||||
Medical condition: Chronic prostatitis and chronic pelvic pain syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) PT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-004578-29 | Sponsor Protocol Number: P.sitsen.01 | Start Date*: 2007-06-15 |
Sponsor Name:Leids Universitair Medisch Centrum | ||
Full Title: The efficacy of intravenous versus rectal paracetamol: A randomized, prospective, double-blind placebo-controlled study | ||
Medical condition: Aims of the study 1)to compare the analgesic efficacy of intravenous versus rectal paracetamol versus placebo as assessed by VAS scores and PCA morphine consumption. 2)To assess the pharmacokinet... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004545-34 | Sponsor Protocol Number: AT10001 | Start Date*: 2006-02-20 |
Sponsor Name:Unit of Esophageal and Gastric Research Dep. of Molecular Medicine and Surgery Karolinska Institutet | ||
Full Title: Can Angiotensin II type 1 Receptor Inhibitor Be Used to Lower the Amount of Lipase and Amylase Level after Endoscopic Retrograde Cholangio-Pancreatography? | ||
Medical condition: The clinical diagnosis of acute pancreatitis is set by a combination of symptoms (abdominal pain) and increased blood levels of pancreatic enzymes (i.e. amylase and lipase). The most common complic... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004353-24 | Sponsor Protocol Number: WMPS | Start Date*: 2014-05-07 | |||||||||||||||||||||
Sponsor Name:Universität Leipzig | |||||||||||||||||||||||
Full Title: Wound Management in Post-Bariatric Surgery Investigation for the reduction of the mean drainage volume in patients after abdominoplasty / lower body lift using Artiss Fibrin Sealant in comparison t... | |||||||||||||||||||||||
Medical condition: Post-bariatric surgery, abdominoplasty, lower body lift | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-000236-22 | Sponsor Protocol Number: Study_protocol_CODEX-P_ver2_1 | Start Date*: 2020-12-16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: COPD EXacerbation and Pulmonary hypertension Trial - The effect of Sildenafil treatment to patients with COPD exacerbation and pulmonary hypertension | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: This study will investigate treatment of patients with chronic obstructive pulmonary disease (COPD), who experience frequent exacerbations (AECOPD). Only patients with a minimum of 2 moderate AECOP... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003637-14 | Sponsor Protocol Number: AGO/2018/004 | Start Date*: 2019-03-29 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: Local injection of collagenase clostridium histolyticum (XiapexR) for refractory gastrointestinal strictures: an open-label pilot study. | |||||||||||||
Medical condition: refractory iatrogenic gastrointestinal strictures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000477-21 | Sponsor Protocol Number: 01579 | Start Date*: 2017-03-27 | |||||||||||
Sponsor Name:Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen | |||||||||||||
Full Title: Reducing antibiotic use for uncomplicated urinary tract infection in gen-eral practice by treatment with Uva ursi - a comparative effectiveness trial | |||||||||||||
Medical condition: uncomplicated urinary tract infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001186-17 | Sponsor Protocol Number: CE1145_3001 | Start Date*: 2005-09-05 | |||||||||||
Sponsor Name:ZLB Behring GmbH | |||||||||||||
Full Title: Human pasteurized C1 esterase inhibitor concentrate (CE1145) in subjects with congenital C1-INH deficiency and acute abdominal or facial HAE attacks | |||||||||||||
Medical condition: Hereditary angioedema (HAE) is characterized by congenital C1-INH deficiency. This is reflected by insufficient plasma concentrations of C1 – inhibitor or by synthesis of dysfunctional C1 – inhibit... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) ES (Completed) CZ (Completed) SE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004702-17 | Sponsor Protocol Number: 1804 | Start Date*: 2012-01-09 | |||||||||||
Sponsor Name:Department of Anaesthesia | |||||||||||||
Full Title: Comparison of Ultrasound - Guided Continuous Rectus Sheath Blockade and Continuous Preperitoneal Wound Catheter Infiltration of Local Anaesthetic for Postoperative Analgesia following Laparotomy. | |||||||||||||
Medical condition: This study will involve the continuous infusion of local anaesthetic, into either the rectus sheath space, or the preperitoneal space, in order to achieve optimal analgesia for patients who have un... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004281-17 | Sponsor Protocol Number: 191622-517 | Start Date*: 2007-12-18 | |||||||||||
Sponsor Name:Allergan Inc. | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study to Evaluate the Safety and Efficacy of a Single Treatment of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Com... | |||||||||||||
Medical condition: Patients with lower urinary tract symptoms due to Benign Prostatic Hyperplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) IT (Completed) GB (Completed) CZ (Completed) AT (Completed) DE (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000202-75 | Sponsor Protocol Number: P.Sitsen.03 | Start Date*: 2007-06-15 |
Sponsor Name:Leids Universitair Medisch Centrum | ||
Full Title: A comparison of the efficacy of levobupivacaine 0,125%, ropivacaine 0,125% and ropivacaine 0,2%, all combined with sufentanil 0.5 micrograms/mL, in patient-controlled epidural analgesia after hyste... | ||
Medical condition: Primary Objective •to compare the analgesic efficacy of levobupivacaine and ropivacaine in patient-controlled epidural analgesia, as assessed by the number of requests for epidural bolus injections... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000239-29 | Sponsor Protocol Number: PEC19156 | Start Date*: 2021-07-09 |
Sponsor Name:BIOGAIA PHARMA | ||
Full Title: A randomized placebo-controlled study to assess safety and preliminary efficacy of BGP345A in patients with constipation due to the use of opioid-based medications for the management of chronic non... | ||
Medical condition: Opioid induced constipation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
